Israel-based Panaxia Pharmaceutical Industries is collaborating with another Israeli pharmaceutical company, Rafa, in conducting a clinical research on the use of medical cannabis concentrates for inhalation. This new delivery method aims to increase accessibility for cancer patients who have been treated with long-term pharmaceutical cannabis like sublingual tablets and for those who are suffering from acute cancer pain but prefer to avoid smoking pot.
Panaxia announced the clinical trial for registration purposes at Israel’s Ministry of Health. The trial will examine the biological availability of delivering medical marijuana via metered-dose inhaler.
The cannabis inhaler includes an attached vaporizer, where the patient will add the measured dose of cannabis extract to be inhaled. This cannabis extract includes a precise dosage of active ingredients.
The metered-dose inhalers containing medical cannabis are expected to be distributed in pharmacies within 2019 under Rafa Pharmaceuticals’ medical cannabis brand. These new products are specifically designed for palliative cancer patients who are suffering from symptoms of cancer pain and who are qualified for medical cannabis treatment.
Dr. Itay Gur-Aryeh, Director of the Pain Unit at Sheba Hospital in Tel Hashomer, said that every clinical research that helps manage medical cannabis treatment is important. He also explained that delivering this treatment via inhalation method is characterized by a quicker response time compared to sublingual or oral tablets.
According to Panaxia CEO Dr. Dadi Segal, the clinical trial is part of the registration process for the new products, which will be marketed by Rafa and which are slated to be launched in the country this year. By allowing patients to access cannabis inhalers, subject to a medical specialist’s prescription or recommendation, the company strives to help more people who are suffering from acute pain. These inhalers will provide those who are not willing or not able to smoke the right to be treated in a precise and consistent manner.